Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster

Journal of Infectious Diseases

Volumn 196, Issue 12, 2007, Pages 1860-1864

  Lamaris, Gregory A ^a   Chamilos, Georgios ^a   Lewis, Russell E ^a   Kontoyiannis, Dimitrios P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; VORICONAZOLE; DROSOPHILA PROTEIN; PYRIMIDINE DERIVATIVE; TOLL LIKE RECEPTOR; TOLL PROTEIN, DROSOPHILA; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONIDIUM; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; FEMALE; FUNGUS TRANSMISSION; FUSARIUM MONILIFORME; HISTOPATHOLOGY; INOCULATION; MORTALITY; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; SCEDOSPORIUM APIOSPERMUM; SURVIVAL; ANIMAL; FUNGUS SPORE; FUSARIUM; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MYCETOMA; PATHOGENICITY; PHYSIOLOGY; SCEDOSPORIUM; VIRULENCE;

ANIMALS; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; FEMALE; FUSARIUM; HUMANS; MADUROMYCOSIS; MYCOSES; PYRIMIDINES; SCEDOSPORIUM; SPORES, FUNGAL; TOLL-LIKE RECEPTORS; TRIAZOLES; VIRULENCE;

EID: 39149088004     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/523765     Document Type: Article

References (14)

1. Lamaris GA, Chamilos G, Lewis RE, Safdar A, Raad II, Kontoyiannis DP. Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006. Clin Infect Dis 2006; 43:1580-4.
2. Torres H, Kontoyiannis DP. Hyalohyphomycoses. In: Dismukes WE, Pappas PG, Sobel JD, eds. Oxford textbook of clinical mycology. New York: Oxford University Press, 2003; 252-70.
3. Chamilos G, Lionakis MS, Lewis RE, Kontoyiannis DP. Role of mini-host models in the study of medically important fungi. Lancet Infect Dis 2007; 7:42-55.
4. Lionakis MS, Lewis RE, May GS, et al. Toll -deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence. J Infect Dis 2005; 191:1188-95.
5. Lionakis MS, Kontoyiannis DP. Fruit flies as a minihost model for studying drug activity and virulence in Aspergillus. Med Mycol 2005; 43:S111-4.
6. Chamilos G, Lionakis MS, Lewis RE, et al. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. J Infect Dis 2006; 193:1014-22.
7. Guarro J, Pujol I, Mayayo E. In vitro and in vivo experimental activities of antifungal agents against Fusarium solani. Antimicrob Agents Chemother 1999; 43:1256-7.
8. Steinbach WJ, Perfect JR. Scedosporium species infections and treatments. J Chemother 2003; 15(Suppl 2):16-27.
9. Graybill JR, Najvar LK, Gonzalez GM, Hernandez S, Bocanegra R. Improving the mouse model for studying the efficacy of voriconazole. J Antimicrob Chemother 2003; 51(6):1373-6.
10. Capilla J, Serena C, Pastor FJ, Ortoneda M, Guarro J. Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice. Antimicrob Agents Chemother 2003; 47:3976-8.
11. Teetor-Barsch GH, Roberts DW. Entomogenous Fusarium species. Mycopathologia 1983; 84:3-16.
12. Ortoneda M, Guarro J, Madrid MP, et al. Fusarium oxysporum as a mini-host model for the genetic dissection of fungal virulence in plants and mammals. Infect Immun 2004; 72:1760-6.
13. Manev H, Dimitrijevic N, Dzitoyeva S. Techniques: fruit flies as models for neuropharmacological research. Trends Pharmacol Sci 2003; 24:41-3.
14. Langfelder K, Streibel M, Jahn B, Haase G, Brakhage AA. Biosynthesis of fungal melanins and their importance for human pathogenic fungi. Fungal Genet Biol 2003; 38:143-58.